4//SEC Filing
Kelly Leanne 4
Accession 0001398278-25-000004
CIK 0001824293other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:06 PM ET
Size
5.8 KB
Accession
0001398278-25-000004
Insider Transaction Report
Form 4
Kelly Leanne
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-18+43,222→ 43,222 totalExercise: $1.93Exp: 2035-09-18→ Common Stock (43,222 underlying)
Footnotes (1)
- [F1]Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.
Documents
Issuer
GRI Bio, Inc.
CIK 0001824293
Entity typeother
Related Parties
1- filerCIK 0001398278
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:06 PM ET
- Size
- 5.8 KB